(EXPE) Expedia - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US30212P3038
Stock: Travel Bookings, Lodging, Accommodations, Travel Technology
Total Rating 61
Risk 52
Buy Signal 0.55
| Risk 5d forecast | |
|---|---|
| Volatility | 55.3% |
| Relative Tail Risk | -19.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.78 |
| Alpha | 10.35 |
| Character TTM | |
|---|---|
| Beta | 1.399 |
| Beta Downside | 2.479 |
| Drawdowns 3y | |
|---|---|
| Max DD | 37.44% |
| CAGR/Max DD | 1.00 |
EPS (Earnings per Share)
Revenue
Description: EXPE Expedia March 05, 2026
Expedia Group, Inc. (EXPE) operates as an online travel company with global reach. Its business model encompasses three segments: B2C, B2B, and trivago.
The B2C segment includes well-known brands like Brand Expedia, Hotels.com, and Vrbo, offering a range of travel products and lodging options, including alternative accommodations. This segment directly serves individual travelers seeking to book travel services online.
The B2B segment provides travel technology and access to its supply network for other businesses, such as airlines, travel agents, and financial institutions. This allows partners to enhance their own offerings with Expedia Groups inventory and rates.
The trivago segment operates hotel metasearch websites, generating revenue by referring users to online travel companies and service providers. This segment focuses on aggregating hotel deals from various sources to present to consumers.
The company employs various marketing strategies, including brand advertising, loyalty programs, and search engine marketing, to attract and retain customers. The online travel sector is characterized by intense competition and a reliance on digital marketing channels. Investors interested in EXPE may find further detailed analysis on ValueRay beneficial for their due diligence.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 1.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 2.18 > 1.0 |
| NWC/Revenue: -30.26% < 20% (prev -27.73%; Δ -2.53% < -1%) |
| CFO/TA 0.16 > 3% & CFO 3.88b > Net Income 1.29b |
| Net Debt (-307.0m) to EBITDA (2.85b): -0.11 < 3 |
| Current Ratio: 0.73 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.2m) vs 12m ago -7.02% < -2% |
| Gross Margin: 88.62% > 18% (prev 0.89%; Δ 8773 % > 0.5%) |
| Asset Turnover: 62.91% > 50% (prev 61.15%; Δ 1.75% > 0%) |
| Interest Coverage Ratio: 6.58 > 6 (EBITDA TTM 2.85b / Interest Expense TTM 299.0m) |
Altman Z'' -0.33
| A: -0.18 (Total Current Assets 12.20b - Total Current Liabilities 16.66b) / Total Assets 24.45b |
| B: 0.07 (Retained Earnings 1.70b / Total Assets 24.45b) |
| C: 0.08 (EBIT TTM 1.97b / Avg Total Assets 23.42b) |
| D: 0.07 (Book Value of Equity 1.50b / Total Liabilities 21.91b) |
| Altman-Z'' Score: -0.33 = B |
Beneish M -2.98
| DSRI: 1.20 (Receivables 4.20b/3.25b, Revenue 14.73b/13.69b) |
| GMI: 1.01 (GM 88.62% / 89.46%) |
| AQI: 0.88 (AQ_t 0.39 / AQ_t-1 0.44) |
| SGI: 1.08 (Revenue 14.73b / 13.69b) |
| TATA: -0.11 (NI 1.29b - CFO 3.88b) / TA 24.45b) |
| Beneish M-Score: -2.98 (Cap -4..+1) = A |
What is the price of EXPE shares?
As of March 07, 2026, the stock is trading at USD 249.62 with a total of 3,615,843 shares traded.
Over the past week, the price has changed by +15.98%, over one month by +5.62%, over three months by -5.39% and over the past year by +36.72%.
Over the past week, the price has changed by +15.98%, over one month by +5.62%, over three months by -5.39% and over the past year by +36.72%.
Is EXPE a buy, sell or hold?
Expedia has received a consensus analysts rating of 3.76.
Therefor, it is recommend to hold EXPE.
- StrongBuy: 13
- Buy: 3
- Hold: 20
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the EXPE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 280.9 | 12.5% |
| Analysts Target Price | 280.9 | 12.5% |
EXPE Fundamental Data Overview March 07, 2026
P/E Trailing = 25.6412
P/E Forward = 11.4548
P/S = 2.0921
P/B = 21.1602
P/EG = 0.5755
Revenue TTM = 14.73b USD
EBIT TTM = 1.97b USD
EBITDA TTM = 2.85b USD
Long Term Debt = 4.47b USD (from longTermDebt, last quarter)
Short Term Debt = 1.69b USD (from shortTermDebt, last quarter)
Debt = 6.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -307.0m USD (from netDebt column, last quarter)
Enterprise Value = 30.20b USD (30.82b + Debt 6.67b - CCE 7.30b)
Interest Coverage Ratio = 6.58 (Ebit TTM 1.97b / Interest Expense TTM 299.0m)
EV/FCF = 8.17x (Enterprise Value 30.20b / FCF TTM 3.69b)
FCF Yield = 12.24% (FCF TTM 3.69b / Enterprise Value 30.20b)
FCF Margin = 25.08% (FCF TTM 3.69b / Revenue TTM 14.73b)
Net Margin = 8.78% (Net Income TTM 1.29b / Revenue TTM 14.73b)
Gross Margin = 88.62% ((Revenue TTM 14.73b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 84.04% (prev 91.48%)
Tobins Q-Ratio = 1.23 (Enterprise Value 30.20b / Total Assets 24.45b)
Interest Expense / Debt = 1.81% (Interest Expense 121.0m / Debt 6.67b)
Taxrate = 16.54% (42.0m / 254.0m)
NOPAT = 1.64b (EBIT 1.97b * (1 - 16.54%))
Current Ratio = 0.73 (Total Current Assets 12.20b / Total Current Liabilities 16.66b)
Debt / Equity = 5.19 (Debt 6.67b / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = -0.11 (Net Debt -307.0m / EBITDA 2.85b)
Debt / FCF = -0.08 (Net Debt -307.0m / FCF TTM 3.69b)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.53% (Net Income 1.29b / Total Assets 24.45b)
RoE = 114.3% (Net Income TTM 1.29b / Total Stockholder Equity 1.13b)
RoCE = 35.10% (EBIT 1.97b / Capital Employed (Equity 1.13b + L.T.Debt 4.47b))
RoIC = 22.38% (NOPAT 1.64b / Invested Capital 7.33b)
WACC = 9.37% (E(30.82b)/V(37.49b) * Re(11.07%) + D(6.67b)/V(37.49b) * Rd(1.81%) * (1-Tc(0.17)))
Discount Rate = 11.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.78%
[DCF] Terminal Value 74.26% ; FCFF base≈3.37b ; Y1≈3.59b ; Y5≈4.30b
[DCF] Fair Price = 505.3 (EV 58.82b - Net Debt -307.0m = Equity 59.12b / Shares 117.0m; r=9.37% [WACC]; 5y FCF grow 7.05% → 2.90% )
EPS Correlation: 45.27 | EPS CAGR: 113.2% | SUE: 2.34 | # QB: 2
Revenue Correlation: 57.04 | Revenue CAGR: 12.92% | SUE: 1.93 | # QB: 2
EPS next Quarter (2026-06-30): EPS=4.99 | Chg7d=+0.000 | Chg30d=+0.218 | Revisions Net=+6 | Analysts=18
EPS current Year (2026-12-31): EPS=19.30 | Chg7d=+0.031 | Chg30d=+1.134 | Revisions Net=+16 | Growth EPS=+21.7% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=22.86 | Chg7d=+0.065 | Chg30d=+1.149 | Revisions Net=+8 | Growth EPS=+18.5% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: +0.60 (8 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 11.1% - Earnings Yield 3.9%)
[Growth] Growth Spread = +1.7% (Analyst 8.9% - Implied 7.2%)
P/E Forward = 11.4548
P/S = 2.0921
P/B = 21.1602
P/EG = 0.5755
Revenue TTM = 14.73b USD
EBIT TTM = 1.97b USD
EBITDA TTM = 2.85b USD
Long Term Debt = 4.47b USD (from longTermDebt, last quarter)
Short Term Debt = 1.69b USD (from shortTermDebt, last quarter)
Debt = 6.67b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -307.0m USD (from netDebt column, last quarter)
Enterprise Value = 30.20b USD (30.82b + Debt 6.67b - CCE 7.30b)
Interest Coverage Ratio = 6.58 (Ebit TTM 1.97b / Interest Expense TTM 299.0m)
EV/FCF = 8.17x (Enterprise Value 30.20b / FCF TTM 3.69b)
FCF Yield = 12.24% (FCF TTM 3.69b / Enterprise Value 30.20b)
FCF Margin = 25.08% (FCF TTM 3.69b / Revenue TTM 14.73b)
Net Margin = 8.78% (Net Income TTM 1.29b / Revenue TTM 14.73b)
Gross Margin = 88.62% ((Revenue TTM 14.73b - Cost of Revenue TTM 1.68b) / Revenue TTM)
Gross Margin QoQ = 84.04% (prev 91.48%)
Tobins Q-Ratio = 1.23 (Enterprise Value 30.20b / Total Assets 24.45b)
Interest Expense / Debt = 1.81% (Interest Expense 121.0m / Debt 6.67b)
Taxrate = 16.54% (42.0m / 254.0m)
NOPAT = 1.64b (EBIT 1.97b * (1 - 16.54%))
Current Ratio = 0.73 (Total Current Assets 12.20b / Total Current Liabilities 16.66b)
Debt / Equity = 5.19 (Debt 6.67b / totalStockholderEquity, last quarter 1.28b)
Debt / EBITDA = -0.11 (Net Debt -307.0m / EBITDA 2.85b)
Debt / FCF = -0.08 (Net Debt -307.0m / FCF TTM 3.69b)
Total Stockholder Equity = 1.13b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.53% (Net Income 1.29b / Total Assets 24.45b)
RoE = 114.3% (Net Income TTM 1.29b / Total Stockholder Equity 1.13b)
RoCE = 35.10% (EBIT 1.97b / Capital Employed (Equity 1.13b + L.T.Debt 4.47b))
RoIC = 22.38% (NOPAT 1.64b / Invested Capital 7.33b)
WACC = 9.37% (E(30.82b)/V(37.49b) * Re(11.07%) + D(6.67b)/V(37.49b) * Rd(1.81%) * (1-Tc(0.17)))
Discount Rate = 11.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.78%
[DCF] Terminal Value 74.26% ; FCFF base≈3.37b ; Y1≈3.59b ; Y5≈4.30b
[DCF] Fair Price = 505.3 (EV 58.82b - Net Debt -307.0m = Equity 59.12b / Shares 117.0m; r=9.37% [WACC]; 5y FCF grow 7.05% → 2.90% )
EPS Correlation: 45.27 | EPS CAGR: 113.2% | SUE: 2.34 | # QB: 2
Revenue Correlation: 57.04 | Revenue CAGR: 12.92% | SUE: 1.93 | # QB: 2
EPS next Quarter (2026-06-30): EPS=4.99 | Chg7d=+0.000 | Chg30d=+0.218 | Revisions Net=+6 | Analysts=18
EPS current Year (2026-12-31): EPS=19.30 | Chg7d=+0.031 | Chg30d=+1.134 | Revisions Net=+16 | Growth EPS=+21.7% | Growth Revenue=+8.1%
EPS next Year (2027-12-31): EPS=22.86 | Chg7d=+0.065 | Chg30d=+1.149 | Revisions Net=+8 | Growth EPS=+18.5% | Growth Revenue=+7.0%
[Analyst] Revisions Ratio: +0.60 (8 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 11.1% - Earnings Yield 3.9%)
[Growth] Growth Spread = +1.7% (Analyst 8.9% - Implied 7.2%)